Current Practices and Future Directions for Treatment of EGFR-Mutated Lung Cancer

home / peer-exchange / current-practices-and-future-directions-for-treatment-of-egfr-mutated-lung-cancer

Thought leaders in thoracic oncology, Neal Navani, MRCP, MSc, PhD, Gary Doherty, MRCP, PhD, Christian Grohé, MD, and Solange Peters, MD, PhD, provide a lively discussion on the impact of molecular testing on treatment algorithms in EGFR-mutant non-small cell lung cancer and share key insights into emerging research on adjuvant treatment options.